Barely Significant
← all excerpts

Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.

Clin Cancer Res · 2022 · PMC9377752 · PMID 34862246

Europe PMCDOI
2
hedged sentences
0.0699
closest p · 1.4× alpha
0.0699
boldest claim

The sentences

borderline significanceP = 0.0699so close (0.05 < p ≤ 0.1)
An association with the EndoPredict clinical score revealed a borderline significance (high vs. low risk, Fisher exact test, P = 0.0699; Supplementary Table S3).

also in 7,017 other papers

did not reach statistical significanceno p-value reported
Although more patients with high EndoPredict clinical scores had ctDNA detected, this association did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.